Tina-quant Transferrin ver.2 (urine application)
Transferrin, Antigen, Antiserum, Control. 510(k) K182095, from Roche Diagnostics Operations (Rdo) (Indianapolis, IN). Product code DDG, class 2.
As of Nov 20, 2026, K182095 is an FDA 510(k) held by Roche Diagnostics Operations (Rdo), substantially equivalent on Nov 5, 2018 after 94 days, with no recalls tied to it in FDA's recall database.
- Review time: 94 days
- Recalls: 0
Tina-quant Transferrin ver.2 (urine application) assay is an in vitro test for the quantitative determination of transferrin in human urine on Roche/Hitachi cobas c systems. A transferrin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the transferrin (an iron-binding and transporting serum protein) in urine.
- N Antisera To Human TransferrinK053075 · Dade Behring, Inc. · Mar 16, 2006
- C.F.A.S. Proteins, C.F.A.S. Pac, Precicontrol Clinchem Multi 1 & 2, Precinorm Protein & Precipath ProteinK133330 · Roche Diagnostics · Nov 26, 2013
- Access sTfRK240987 · Beckman Coulter, Inc. · Jul 3, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 3, 2018
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5880
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files